CAD 146,063.00
Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.
Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.
This is the whole reported commitment or notice value, not the amount paid or an NL allocation.
- Recipient
- JRAS Medical Inc.
- Public body
- National Research Council Canada
- Agreement start
- June 20, 2025
- Program
- Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
- Record type
- Federal grant or contribution
Receipt
agreement 172-2025-2026-Q1-1029860, amendment 0
Source location evidence
Location review incomplete.
Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1C 1S9.
How counted: latest of 1 rows (department reports running totals). Start: 2025-06-20; end: 2026-08-31; reported: not stated. Amount: published value.
Full source fields
- _id
- 35934301
- ref_number
- 172-2025-2026-Q1-1029860
- amendment_number
- 0
- amendment_date
- agreement_type
- C
- recipient_type
- F
- recipient_business_number
- 767414923
- recipient_legal_name
- JRAS Medical Inc.
- recipient_operating_name
- research_organization_name
- recipient_country
- CA
- recipient_province
- NL
- recipient_city
- St. John's|St. John's
- recipient_postal_code
- A1C 1S9
- federal_riding_name_en
- St. John's East
- federal_riding_name_fr
- St. John's-Est
- federal_riding_number
- 10006
- prog_name_en
- Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
- prog_name_fr
- Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
- prog_purpose_en
- Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
- prog_purpose_fr
- Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
- agreement_title_en
- Non-invasive Home Heart Failure Monitoring
- agreement_title_fr
- Surveillance non invasive à domicile de l’insuffisance cardiaque
- agreement_number
- 1029860
- agreement_value
- 146063.0
- foreign_currency_type
- foreign_currency_value
- agreement_start_date
- 2025-06-20
- agreement_end_date
- 2026-08-31
- coverage
- description_en
- Heart failure is a devasting and chronic disease affecting an estimated 600,000 Canadians. It is characterized by episodes of severe shortness of breath and leg swelling resulting in frequent, prolonged hospital admissions and often high rate of hospital readmission. Congestive Heart Failure (CHF) symptoms are caused by pressure build-up within the heart. JVPLabs, in collaboration with the National Research Council, plans on developing a noninvasive home heart failure monitoring device that assesses key physiologic parameters important to the management of heart failure. The data collected by the JVPLabs device is transmitted to the heart failure clinical team enabling adjustment of medications that will keep the patient feeling well in the comfort of their own home.
- description_fr
- L’insuffisance cardiaque est une maladie chronique dévastatrice qui affecte environ 600 000 Canadiens et Canadiennes. Elle se manifeste par des épisodes de grave essoufflement et d’enflure des jambes, entraînant des hospitalisations fréquentes et prolongées, ainsi qu’un taux élevé de réadmissions. Les symptômes de l’insuffisance cardiaque congestive (ICC) résultent d’une accumulation de pression dans le cœur. JVPLabs, en partenariat avec le Conseil national de recherches du Canada, prévoit de mettre au point un dispositif non invasif de surveillance à domicile de l’insuffisance cardiaque. Ce dispositif évaluera les principaux paramètres physiologiques essentiels à la gestion de l’insuffisance cardiaque. Les données recueillies par le dispositif de JVPLabs sont transmises à l’équipe clinique spécialisée en insuffisance cardiaque, ce qui permet d’ajuster les médicaments afin que le patient se sente bien dans le confort de son foyer.
- naics_identifier
- 541710
- expected_results_en
- In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
- expected_results_fr
- À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
- additional_information_en
- additional_information_fr
- owner_org
- nrc-cnrc
- owner_org_title
- National Research Council Canada | Conseil national de recherches Canada
Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.